Literature DB >> 17457176

Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway?

Karim Brohi1, Mitchell J Cohen, Michael T Ganter, Michael A Matthay, Robert C Mackersie, Jean-François Pittet.   

Abstract

OBJECTIVES: Coagulopathy following major trauma is conventionally attributed to activation and consumption of coagulation factors. Recent studies have identified an acute coagulopathy present on admission that is independent of injury severity. We hypothesized that early coagulopathy is due to tissue hypoperfusion, and investigated derangements in coagulation associated with this.
METHODS: This was a prospective cohort study of major trauma patients admitted to a single trauma center. Blood was drawn within 10 minutes of arrival for analysis of partial thromboplastin and prothrombin times, prothrombin fragments 1+2, fibrinogen, thrombomodulin, protein C, plasminogen activator inhibitor-1, and D-dimers. Base deficit (BD) was used as a measure of tissue hypoperfusion.
RESULTS: A total of 208 patients were enrolled. Patients without tissue hypoperfusion were not coagulopathic, irrespective of the amount of thrombin generated. Prolongation of the partial thromboplastin and prothrombin times was only observed with an increased BD. An increasing BD was associated with high soluble thrombomodulin and low protein C levels. Low protein C levels were associated with prolongation of the partial thromboplastin and prothrombin times and hyperfibrinolysis with low levels of plasminogen activator inhibitor-1 and high D-dimer levels. High thrombomodulin and low protein C levels were significantly associated with increased mortality, blood transfusion requirements, acute renal injury, and reduced ventilator-free days.
CONCLUSIONS: Early traumatic coagulopathy occurs only in the presence of tissue hypoperfusion and appears to occur without significant consumption of coagulation factors. Alterations in the thrombomodulin-protein C pathway are consistent with activated protein C activation and systemic anticoagulation. Admission plasma thrombomodulin and protein C levels are predictive of clinical outcomes following major trauma.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17457176      PMCID: PMC1877079          DOI: 10.1097/01.sla.0000256862.79374.31

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  34 in total

1.  Reconstitution of the human endothelial cell protein C receptor with thrombomodulin in phosphatidylcholine vesicles enhances protein C activation.

Authors:  J Xu; N L Esmon; C T Esmon
Journal:  J Biol Chem       Date:  1999-03-05       Impact factor: 5.157

2.  Coagulopathy after successful cardiopulmonary resuscitation following cardiac arrest: implication of the protein C anticoagulant pathway.

Authors:  Christophe Adrie; Mehran Monchi; Ivan Laurent; Suzan Um; S Betty Yan; Marie Thuong; Alain Cariou; Julien Charpentier; Jean François Dhainaut
Journal:  J Am Coll Cardiol       Date:  2005-07-05       Impact factor: 24.094

Review 3.  The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination.

Authors:  G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg
Journal:  Am J Respir Crit Care Med       Date:  1994-03       Impact factor: 21.405

4.  The relationship of base deficit to lactate in porcine hemorrhagic shock and resuscitation.

Authors:  J W Davis
Journal:  J Trauma       Date:  1994-02

5.  Pulmonary contusions: quantifying the lesions on chest X-ray films and the factors affecting prognosis.

Authors:  J G Tyburski; J D Collinge; R F Wilson; S R Eachempati
Journal:  J Trauma       Date:  1999-05

6.  Admission base deficit predicts transfusion requirements and risk of complications.

Authors:  J W Davis; S N Parks; K L Kaups; H E Gladen; S O'Donnell-Nicol
Journal:  J Trauma       Date:  1996-11

7.  A prospective study of venous thromboembolism after major trauma.

Authors:  W H Geerts; K I Code; R M Jay; E Chen; J P Szalai
Journal:  N Engl J Med       Date:  1994-12-15       Impact factor: 91.245

8.  Base deficit stratifies mortality and determines therapy.

Authors:  E J Rutherford; J A Morris; G W Reed; K S Hall
Journal:  J Trauma       Date:  1992-09

9.  Hypercoagulability following multiple trauma.

Authors:  D T Engelman; S G Gabram; L Allen; G E Ens; L M Jacobs
Journal:  World J Surg       Date:  1996-01       Impact factor: 3.352

10.  Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma: application of clinical decision analysis.

Authors:  S Gando; S Nanzaki; O Kemmotsu
Journal:  Ann Surg       Date:  1999-01       Impact factor: 12.969

View more
  188 in total

1.  Early release of soluble receptor for advanced glycation endproducts after severe trauma in humans.

Authors:  Mitchell J Cohen; Michel Carles; Karim Brohi; Carolyn S Calfee; Pamela Rahn; Mariah S Call; Brian B Chesebro; Michael A West; Jean-François Pittet
Journal:  J Trauma       Date:  2010-06

2.  Clotting factor deficiency in early trauma-associated coagulopathy.

Authors:  Sandro B Rizoli; Sandro Scarpelini; Jeannie Callum; Bartolomeu Nascimento; Kenneth G Mann; Ruxandra Pinto; Jan Jansen; Homer C Tien
Journal:  J Trauma       Date:  2011-11

3.  Cause and timing of death in massively transfused trauma patients.

Authors:  Michael W Cripps; Matthew E Kutcher; Aaron Daley; Ryan C McCreery; Molly D Greenberg; Leslie M Cachola; Brittney J Redick; Mary F Nelson; Mitchell Jay Cohen
Journal:  J Trauma Acute Care Surg       Date:  2013-08       Impact factor: 3.313

Review 4.  Protocols for massive blood transfusion: when and why, and potential complications.

Authors:  E Guerado; A Medina; M I Mata; J M Galvan; M L Bertrand
Journal:  Eur J Trauma Emerg Surg       Date:  2015-12-09       Impact factor: 3.693

5.  [Coagulation management in multiple trauma].

Authors:  M Wilhelmi
Journal:  Unfallchirurg       Date:  2014-02       Impact factor: 1.000

6.  The tissue factor pathway mediates both activation of coagulation and coagulopathy after injury.

Authors:  Benjamin M Howard; Byron Y Miyazawa; Weifeng Dong; Wendy J Cedron; Ryan F Vilardi; Wolfram Ruf; Mitchell Jay Cohen
Journal:  J Trauma Acute Care Surg       Date:  2015-12       Impact factor: 3.313

7.  Systemic hyperfibrinolysis after trauma: a pilot study of targeted proteomic analysis of superposed mechanisms in patient plasma.

Authors:  Anirban Banerjee; Christopher C Silliman; Ernest E Moore; Monika Dzieciatkowska; Marguerite Kelher; Angela Sauaia; Kenneth Jones; Michael P Chapman; Eduardo Gonzalez; Hunter B Moore; Angelo D'Alessandro; Erik Peltz; Benjamin E Huebner; Peter Einerson; James Chandler; Arsen Ghasabayan; Kirk Hansen
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

8.  Trauma hemostasis and oxygenation research position paper on remote damage control resuscitation: definitions, current practice, and knowledge gaps.

Authors:  Donald H Jenkins; Joseph F Rappold; John F Badloe; Olle Berséus; Lorne Blackbourne; Karim H Brohi; Frank K Butler; Andrew P Cap; Mitchell Jay Cohen; Ross Davenport; Marc DePasquale; Heidi Doughty; Elon Glassberg; Tor Hervig; Timothy J Hooper; Rosemary Kozar; Marc Maegele; Ernest E Moore; Alan Murdock; Paul M Ness; Shibani Pati; Todd Rasmussen; Anne Sailliol; Martin A Schreiber; Geir Arne Sunde; Leo M G van de Watering; Kevin R Ward; Richard B Weiskopf; Nathan J White; Geir Strandenes; Philip C Spinella
Journal:  Shock       Date:  2014-05       Impact factor: 3.454

Review 9.  Coagulopathy associated with traumatic brain injury.

Authors:  Monisha A Kumar
Journal:  Curr Neurol Neurosci Rep       Date:  2013-11       Impact factor: 5.081

10.  Rapid TEG efficiently guides hemostatic resuscitation in trauma patients.

Authors:  Julia R Coleman; Ernest E Moore; Michael P Chapman; Anirban Banerjee; Christopher C Silliman; Arsen Ghasabyan; James Chandler; Jason M Samuels; Angela Sauaia
Journal:  Surgery       Date:  2018-06-12       Impact factor: 3.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.